Treating MERS-CoV during an outbreak

Lancet Infect Dis. 2014 Nov;14(11):1030-1031. doi: 10.1016/S1473-3099(14)70939-9. Epub 2014 Sep 29.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antiviral Agents / therapeutic use*
  • Coronavirus Infections / drug therapy*
  • Female
  • Humans
  • Interferon alpha-2
  • Interferon-alpha / therapeutic use*
  • Male
  • Middle East Respiratory Syndrome Coronavirus / drug effects*
  • Recombinant Proteins / therapeutic use
  • Ribavirin / therapeutic use*

Substances

  • Antiviral Agents
  • Interferon alpha-2
  • Interferon-alpha
  • Recombinant Proteins
  • Ribavirin